See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.31▲ 0.84%
Vienna Exchange · Austria · Updated after 15 Oct 2026 close

Marinomed Biotech AG

MARI · Vienna Exchange · prices in EUR
EUR 4.000▲ +0.000 (0.00%)
Research reportHistorical data

About Marinomed Biotech AG

Marinomed Biotech AG is an Austrian biopharmaceutical company based in Korneuburg. It develops and licenses products built on its own technology platforms, including a polymer derived from red algae used in nasal sprays and lozenges that address cold and allergy symptoms, and a solubilising technology that improves the delivery of poorly soluble drugs. The company works with commercial partners to bring its consumer health products to pharmacies and markets in several countries, while also pursuing prescription applications of its platforms.

On this site Marinomed Biotech AG appears as a stock on the Vienna Exchange (Austria), code MARI, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

5/ 100
Market X-Ray · price-based
Weak price profile
Ranks #84 of 84 on the Vienna Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Austria yet.
TrendWeak
1/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-63.2%
From 52-week high-81.0%
MomentumWeak
2/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-55.3%
6-month return-71.0%
12-month, skipping last month-77.4%
Stability (higher is calmer)Weak
2/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)105.9%
Worst drawdown, 1 year (smaller is calmer)-81.9%
LiquidityWeak
22/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.00M EUR
Zero-volume days35.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Austria when fundamentals data for this market is added. All Austria stocks.
Price trend
Below its 200-day average
Versus its 50- and 200-day averages
52-week range
2.200 – 21.000
Price is 10% of the way up
Returns
−55.3% 3m · −79.9% 1y
Price returns, dividends not included
RSI (14)
33
Neutral zone

Price chart

52-wk range 2.200 – 21.000 Daily closes, split-adjusted

Signals

50-day average4.366
200-day average10.867
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.044

Technical summary

Daily
Strongly bearish
0 bullish · 3 neutral · 11 bearish
Weekly
Strongly bearish
1 bullish · 0 neutral · 11 bearish
Monthly
Strongly bearish
1 bullish · 0 neutral · 7 bearish
Moving averages (daily)
SMA 104.00Bearish
EMA 104.01Bearish
SMA 204.05Bearish
EMA 204.09Bearish
SMA 504.37Bearish
EMA 504.73Bearish
SMA 1006.39Bearish
EMA 1006.49Bearish
SMA 20010.87Bearish
EMA 2009.51Bearish
Oscillators (daily)
RSI (14)32.99Neutral
MACD (12, 26)-0.15Bearish
Momentum (12)0.00Neutral
Stochastic %K (14)–n/a
Williams %R (14)–n/a
CCI (20)-37.04Neutral
Pivot points (classic, last session)
S3
4.00
S2
4.00
S1
4.00
Pivot
4.00
R1
4.00
R2
4.00
R3
4.00
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.

Prices are end-of-day closes in EUR. Educational only, not financial advice.